Featured Research

from universities, journals, and other organizations

Novel Version Of Common Virus Pitted Against Cancer

Date:
June 21, 2007
Source:
University of Rochester Medical Center
Summary:
Scientists are testing a new innovation in biotherapy by altering a common childhood respiratory virus, the adenovirus, to destroy cancer cells.

With nearly $1 million in government funding, University of Rochester scientists are testing a new innovation in biotherapy by altering a common childhood respiratory virus, the adenovirus, to destroy cancer cells.

Related Articles


Exploring the potential of biotherapy through oncolytic adenoviruses is a hot area in cancer research. The approach is analogous to the police employing a snitch to reach the bad guys: For years scientists have been engineering relatively benign viruses to selectively infiltrate and deliver genetic materials into more dangerous cells.

However, the current generation of mutant viruses under study has limitations. So far, they are proving to be effective only in tumor cells that express certain proteins. The Rochester group designed an entirely new version of the adenovirus that might have broader, more powerful potential. The first experiments will be on pancreatic cancer, one of the deadliest malignancies.

"Our concept is very promising and we hope it will open the door to safer and more effective treatments," said Baek Kim, Ph.D., associate professor of Microbiology and Immunology at the University of Rochester Medical Center and study co-investigator. "If this works, the most exciting part is that patients would be able to generate their own internal weapons to kill the malignant cells without having to endure a toxic element such as chemotherapy."

Kim and co-investigator Stephen Dewhurst, Ph.D., senior associate dean for basic research at the University of Rochester, began looking at a novel approach to cancer treatment after investigating HIV/AIDS. Even though HIV and cancer are unrelated illnesses, they discovered a common link in the deadly efficiency of HIV cells and cancer cells.

Cancer cells are known to have a high concentration of dNTP, a building block of DNA. In fact, cancer cells require high dNTP concentrations in order to replicate their chromosomes fast enough to continually divide and invade the body. Two years ago, Dewhurst and Kim discovered that a driving force behind HIV's efficiency was also its unique ability to use dNTP to make DNA. Indeed, the DNA polymerase (an enzyme) of HIV allows the virus to infect cells within the immune system that lack dNTP.

They wondered if they could make a mutant form of HIV that could go head-to-head against cancer, binding to the dNTP and replicating only in malignant cells.

"This theory was a terrific but it had one big problem: you cannot test it in people because you cannot give people HIV," explained Kim. "So we had to find another route. That's when we came up with the idea of modifying the adenovirus with dNTP."

Thus, the Rochester team set out to construct a new weapon. Their adenovirus vector contains mutant DNA polymerase (dNTP) that should activate only in cells with a high concentration of dNTP, such as cancer cells. Once the virus enters the cancer cell, it should also create new "soldiers" to destroy neighboring cancer cells while leaving normal cells alone, Kim said.

When the job is done, the adenovirus should die out. Side effects should be minimal. Since the adenovirus does not contain toxic elements, the worst-case scenario would be that it would cause an infection in the body's healthy cells, producing flu-like symptoms that are treatable, Kim said.

Investigators are testing the concept in mice and in the laboratory with human pancreatic cancer cells. Pancreatic cancer was selected because of its poor prognosis and current lack of effective therapies. Although it accounts for only about two percent of new cancer cases diagnosed annually in the United States, it accounts for six percent of cancer deaths.

The National Cancer Institute and the U.S. Department of Defense is funding the research.


Story Source:

The above story is based on materials provided by University of Rochester Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

University of Rochester Medical Center. "Novel Version Of Common Virus Pitted Against Cancer." ScienceDaily. ScienceDaily, 21 June 2007. <www.sciencedaily.com/releases/2007/06/070620154921.htm>.
University of Rochester Medical Center. (2007, June 21). Novel Version Of Common Virus Pitted Against Cancer. ScienceDaily. Retrieved January 29, 2015 from www.sciencedaily.com/releases/2007/06/070620154921.htm
University of Rochester Medical Center. "Novel Version Of Common Virus Pitted Against Cancer." ScienceDaily. www.sciencedaily.com/releases/2007/06/070620154921.htm (accessed January 29, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Thursday, January 29, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Malnutrition on the Rise as Violence Flares in C. Africa

Malnutrition on the Rise as Violence Flares in C. Africa

AFP (Jan. 28, 2015) Violence can flare up at any moment in Bambari with only a bridge separating Muslims and Christians. Malnutrition is on the rise and lack of water means simple cooking fires threaten to destroy makeshift camps where people are living. Duration: 00:40 Video provided by AFP
Powered by NewsLook.com
Poultry Culled in Taiwan to Thwart Bird Flu

Poultry Culled in Taiwan to Thwart Bird Flu

Reuters - News Video Online (Jan. 28, 2015) Taiwan culls over a million poultry in efforts to halt various strains of avian flu. Julie Noce reports. Video provided by Reuters
Powered by NewsLook.com
Media Criticizing Parents For Not Vaccinating Children

Media Criticizing Parents For Not Vaccinating Children

Newsy (Jan. 28, 2015) As the Disneyland measles outbreak continues to spread, the media says parents who choose not to vaccinate their children are part of the cause. Video provided by Newsy
Powered by NewsLook.com
Shark Bite Victim Making Amazing Recovery

Shark Bite Victim Making Amazing Recovery

AP (Jan. 27, 2015) A Texas woman who lost more than five pounds of flesh to a shark in the Bahamas earlier this month could be released from a Florida hospital soon. Experts believe she was bitten by a bull shark while snorkeling. (Jan. 27) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins